Congratulations to the 2023 Mount Sinai Emergency Nurse Awardees

The Department of Emergency Medicine at Mount Sinai celebrated the Second Annual Emergency Nurse Awards in recognition of Emergency Nurses Week.

At Mount Sinai, there are more than 700 emergency nursing team members committed to caring for our patients within our Emergency Departments and across the Mount Sinai Health System.

The ceremony, held Tuesday, October 9 in the Hatch Auditorium at The Mount Sinai Hospital, honored 40 emergency nursing team members across seven categories.

Opening remarks by Mount Sinai leadership included Robin Ferrer, MBA, MSN, RN, System Vice President of Emergency Medicine; Beth Oliver, DNP, RN, FAAN, Chief Nurse Executive and Senior Vice President, Cardiac Services; and David Reich, MD, President of The Mount Sinai Hospital and Mount Sinai Queens who spoke about the positivity and optimism displayed every day by emergency nurses.

Afterwards, awardees and their families gathered with fellow team members to celebrate.

Rookie of the Year Award

The recipient for this category has eighteen months or less experience working in the Emergency Department and consistently displays confidence, initiative and high potential in providing clinical care and contributing to the team’s success.

Mount Sinai West: Katherine Schuerger

Mount Sinai Brooklyn: Jennifer Yun

Mount Sinai Queens: Saskia Moore (not pictured)

The Mount Sinai Hospital: Donovan Carey

Mount Sinai Morningside: Xinyue Zheng

Mount Sinai Beth Israel: Nicole Brophy

Mount Sinai South Nassau: Gianni Lise Delgado-Gaines

Preceptor of the Year Award

The recipient for this category serves as a resource and mentor for team members and new hires by sharing knowledge and skills and exemplifying best practices in providing care to our community of patients.

Mount Sinai West: Emma Frankel

Mount Sinai Brooklyn: Valerie Merrell (not pictured)

Mount Sinai Queens: Eric Peterson

The Mount Sinai Hospital: Rachel Miguel

Mount Sinai Morningside: Corine Lamy

Mount Sinai Beth Israel: Hermia Bertrand

Mount Sinai South Nassau: Meghan Evans (not pictured)

Support Staff Member of the Year Award

The recipient for this category demonstrates support of and collaboration with nursing staff through effective teamwork, clear communication, focus on patient safety, and enhancing the overall experience for patients and families.

Mount Sinai West: Vincent Love

Mount Sinai Brooklyn: Gilbert Quiocho (not pictured)

Mount Sinai Queens: Jessica Vicuna (not pictured)

The Mount Sinai Hospital: Hamid Usman (not pictured)

Mount Sinai Morningside: Alicia Clayton(not pictured)

Mount Sinai Beth Israel: Edgardo Calderon (not pictured)

Mount Sinai South Nassau: Ricardo Ventura

Resilience and Wellness Award

The recipient for this category serves as a role model for resilience and wellness by exemplifying healthy habits and lifestyle, and also helps to promote Mount Sinai resiliency resources and engages others in healthy habits.

Mount Sinai West: Virginia Torres

The Mount Sinai Hospital: Cynthia Mendez

Mount Sinai Morningside: Larissa Leonardo

Mount Sinai South Nassau: David Lee

Emergency Department Clinical Nurse of the Year Award

The recipient for this category is a staff nurse who adheres to nursing standards of practice, and consistently demonstrates exceptional patient care and professionalism. This nurse helps facilitate positive team engagement and high-quality patient outcomes.

Mount Sinai West: Rosemarie Yetman

Mount Sinai Brooklyn: Yelena Shneyder (not pictured)

Mount Sinai Queens: Amparo Sullivan (not pictured)

The Mount Sinai Hospital: Joel Madrid and Nicole Kostakis

Mount Sinai Morningside: Charles Hillman

Mount Sinai Beth Israel: Judy Louie

Mount Sinai South Nassau: Megan Probst

Emergency Department Nurse Leader of the Year Award

The recipient for this category demonstrates excellent leadership skills by serving as a resource through effective communication, working to inspire passion, and promoting professional development. This leader motivates, supports, and creates a high-performance culture for the team.

Mount Sinai West: Nicole Ferrell, Assistant Nurse Manager

Mount Sinai Brooklyn: Lilibeth Pansoy, Clinical Staff Nurse (not pictured)

Mount Sinai Queens: Eileen Brown-Mighty, Nurse Manager (not pictured)

The Mount Sinai Hospital: Olivia Sgambellone, Interim Nurse Manager

Mount Sinai Morningside: Anthony Duncan, Director of Nursing

Mount Sinai Beth Israel: Shari Weisburd, Nurse Manager

Mount Sinai South Nassau: Christopher Brown, Assistant Nurse Manager

Emergency Nursing Team Award 2023

This new category was awarded to The Mount Sinai Hospital Emergency Department Team in recognition of their work and dedication when in August they were selected as a 2023 Lantern Award recipient by the Emergency Nurses Association. The prestigious Lantern Award is a symbol of an emergency department’s commitment to quality, safety, a healthy work environment, and innovation in nursing practice and emergency care. The Mount Sinai Hospital is one of 53 emergency departments in the United States recognized with the Lantern Award.

VF Society Gathers to Celebrate Mentor Valentin Fuster, MD, PhD, and Share Insights in Cardiology

Valentin Fuster, MD, PhD, with physicians in the VF Society, an association of alumni that recently held its 18th Anniversary Dinner.

The Valentin Fuster (VF) Society, a nonprofit alumni association composed  of graduates of the Zena and Michael A. Wiener Cardiovascular Institute, recently held its 18th Anniversary Dinner at the New York Academy of Medicine. One-hundred-twenty alumni attended the event to discuss academic and clinical ideas, reconnect with former colleagues, and express profound appreciation of Valentin Fuster, MD, PhD, President of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital.

Graduates who have trained with Dr. Fuster created the VF Society to strengthen the bond among alumni and The Mount Sinai Hospital. More than 250 alumni who have trained under Dr. Fuster since 1981 belong to the VF Society. The anniversary dinner is generally held every two years, drawing VF Society members from across the United States and Canada. This year’s gathering was the first since the start of the COVID-19 pandemic.

“Besides being an extraordinary clinician and mentor, Dr.  Fuster takes a genuine interest in each and every fellow’s life. They keep in touch with him and seek his guidance throughout their distinguished careers,” said Martin Goldman, MD, the Dr. Arthur M. and Hilda A. Master Professor of Medicine (Cardiology), Program Director of the Cardiovascular Disease Fellowship Program, and an organizer of the event.

The evening included a panel discussion on the current and future state of cardiology with Dr. Fuster and Eugene Braunwald, MD, the Hersey Professor of Medicine at Harvard Medical School, moderated by Deepak L. Bhatt, MD, MPH, Director of Mount Sinai Heart and the Dr. Valentin Fuster Professor of Cardiovascular Medicine, and Dr. Goldman. Dr. Bhatt said, “It was an extraordinary, once-in-a-lifetime event to see these two cardiovascular legends discuss the key issues in cardiovascular medicine.”

“This celebration was an important opportunity to share scientific information and insights in our field and to strengthen the camaraderie unique to fellows that I have had the privilege to train,” said Dr. Fuster.

Mount Sinai Researcher Launches Three Studies of Alzheimer’s Disease in Asian Americans

Clara Li, PhD, a clinical neuropsychologist and Associate Professor, Psychiatry, at the Icahn School of Medicine at Mount Sinai, has received new grants that will total more than $12 million from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH). The funding will support three new projects that seek to improve the diagnosis and treatment of Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD) in Asian Americans.

Asian Americans are historically under-represented in clinical research on AD/ADRD. As a result, many older adults with Asian ancestry do not receive adequate diagnosis and treatment for mild cognitive impairment (MCI) or AD/ADRD.

Clara Li, PhD

“Chinese is the third-most-spoken language in the United States after English and Spanish, yet we don’t have many of these tools available,” Dr. Li explains. She’s hoping to change that, with three new studies launched in 2023.

Adapting Assessments for Alzheimer’s: Chinese Translation and Cultural Adaptation

In one of the studies, a five-year effort, Dr. Li will develop assessment tools that are linguistically and culturally adapted for older adults who speak Cantonese or Mandarin, with the hope to extend it to other Asian languages in the future.

Researchers rely on assessment tools from the National Alzheimer’s Coordinating Center Uniform Data Set (NACC UDS) to identify research participants with cognitive impairment or AD/ADRD. But those tests were developed for English speakers and Western cultures.

“I’ve seen many Asian American patients who try to take the English tests because a Chinese version isn’t available, and the language is a barrier,” Dr. Li says. “Sometimes a test would suggest cognitive impairment, but when I would translate the test myself into Chinese, the patient would score in the normal range.”

Language isn’t the only barrier. Cultural differences also make the test confusing for many Asian American patients. When asked to identify an image of a witch on the standard test, for instance, some of Dr. Li’s patients said “janitor” or “cleaner”—a common error because witches aren’t typically depicted with brooms in Chinese culture.

The lack of adequate tests hampers diagnosis and treatment, and also affects research seeking to better understand AD/ADRD in Asian Americans.

“Because we can’t enroll patients unless they can take the tests in English, many are excluded from studies. As a result, Asian Americans make up less than 2 percent of the participants in U.S. clinical trials,” Dr. Li explains. “If we want to increase diversity in research, we need to adapt these materials for Chinese speakers and eventually other Asian languages.”

A Research Infrastructure for Alzheimer’s Disease in Asian Americans

In the second study, Dr. Li will develop a research infrastructure and tools for studying AD/ADRD in older Asian Americans. She and her colleagues will develop questionnaires to fully characterize Asian American participants, including social determinants of health and any environmental or lifestyle factors that could increase or decrease their risk of developing AD/ADRD.

This five-year study will also investigate blood samples from Asian American participants to determine whether there may be novel biomarkers in this population, and whether known biomarkers are relevant to people from Asian backgrounds.

“Amyloid and tau are well known as biomarkers associated with Alzheimer’s disease, but those biomarkers were developed primarily from Caucasian samples. Therefore, the generalization of these findings in Asian Americans is not always clear, including criteria for amyloid and tau burden to establish AD/ADRD risk,” she says. “There may be different thresholds for those biomarkers in different populations.”

Support for Mild Cognitive Impairment

Dr. Li’s third newly funded project is a two-year pilot clinical trial. She and her colleagues will adapt the Memory Support System (MSS) for use in Chinese Americans who speak Cantonese or Mandarin. The MSS is a memory calendar training program to help older adults with MCI organize and remember their daily activities. The system is a component of the Healthy Action to Benefit Independence & ThinkingÒ (HABIT) Program, an evidence-based intervention that provides lifestyle and behavioral treatments for older adults with MCI.

“I see patients with MCI who want to do something to prevent the development of dementia, but if they can’t speak fluent English, they aren’t able to participate in clinical trials,” Dr. Li says. “We hope that by adapting this program, we can offer Chinese American older adults with MCI an opportunity to participate in a trial that seeks to improve memory and function, as well as their mood and quality of life.”

Alzheimer’s Disease Research at Mount Sinai

In addition to the three new studies Dr. Li has launched this year, she is leading two clinical trials at the Alzheimer’s Disease Research Center at Icahn Mount Sinai and is the site Principal Investigator for the Asian Cohort for Alzheimer’s Disease (ACAD) study, a multisite project to analyze genetic data to identify risk variants for Alzheimer’s disease in Asian Americans and Asian Canadians.

Through these projects, she hopes to improve research participation, diagnosis, and treatment related to patients of Asian ancestry—an effort that is long overdue, she says.

“There’s a lot of work that needs to be done. In addition to research inequities, there aren’t enough bilingual physicians outside the community, which often makes it difficult for Asian American older adults to receive integrated specialty care, leading to delayed diagnosis and treatment for AD/ADRD,” she adds.

Mount Sinai serves a diverse patient population and is committed to improving care by addressing bias and racism. Icahn Mount Sinai and Mount Sinai Health System created the Center for Asian Equity and Professional Development to address the equity and professional development challenges faced by Asian Americans and Pacific Islanders.

Mount Sinai Receives Five-Year Grant to Support First-of-Its-Kind Translational Science Program for Nurses

Mount Sinai’s Center for Nursing Research and Innovation (CNRI) is developing a first-of-its-kind program that supports Doctor of Nursing Practice (DNP) students from underrepresented minority communities and disadvantaged backgrounds to become experts in translating research into clinical practice. The program’s development is being funded by a five-year grant from the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health.

“We are so excited to have achieved this significant milestone,” says Kimberly Souffront, PhD, RN, FNP-BC, Associate Director of CNRI. “This initiative is a significant step toward fostering diversity, equity, and inclusion in our research and health care communities. It not only creates opportunities for underrepresented DNP students but also underscores the vital role of diverse perspectives in advancing translational research and eliminating health disparities.”

The 12-week summer program, Translational Research and Implementation Science for Nurses (TRAIN) at Mount Sinai, will provide DNP students with impactful translational research mentorship within the clinical setting. TRAIN will deliver collaborative, multidisciplinary, multispecialty classroom education and hands-on research experiences mentored by experts in fields of health disparities, hypertension, and other clinical topics central to the NHLBI mission. Students who meet the criteria and are enrolled in any accredited DNP program are eligible to apply.

“DNP-prepared nurses from diverse backgrounds are uniquely and exceptionally qualified to lead translational research for advancing health equity,” says Bevin Cohen, PhD, MS, MPH, RN, CNRI Director.

The inaugural TRAIN program will run from Tuesday, May 28, through Friday, August 16, 2024, with participants devoting 30 hours per week to program activities. A generous stipend is provided to offset the financial impact of professional development in this critical field.

“Having nurses who are prepared to participate as full partners in the research enterprise is critically important,” says Lynne Richardson, MD, FACEP, Founding Co-Director of the Institute for Health Equity Research at Mount Sinai and Endowed Professor of Emergency Medicine and Health Equity Science, Icahn School of Medicine at Mount Sinai. “TRAIN will build the pool of doctoral nurses who are engaged in translational research and implementation science.”

Those interested in learning more about the TRAIN program can email questions to TRAIN@mountsinai.org.

Public Health and Racial Justice Program Encourages Girls of Color to See Themselves As Agents of Change

The Mount Sinai Department of Health Education, with support from The Blavatnik Family Women’s Health Research Institute, hosted its first in-person cohort of the Public Health and Racial Justice Program. Over the course of six weeks in July and August, 15 youth participants, all identifying as girls of color, met daily at The Mount Sinai Hospital to explore a variety of public health issues through a racial justice lens.

The Public Health and Racial Justice Program emphasizes the power and importance of civic engagement, community organizing, and youth activism in addressing the inequities that drive health disparities. The program aims to build skills, foster pride, and nurture community connection so that participants understand themselves as lifelong stakeholders invested in shaping the policies, institutions, and structures that affect the health and well-being of their families and their communities.

“Hearing from both younger people and people who were actively involved in their communities and making a difference was inspiring and presented tangible ways for me to get involved in the community.”

The Public Health and Racial Justice Program was designed and launched in the spring of 2020 as a direct response to the COVID-19 pandemic and the Black Lives Matter movement. Due to pandemic restrictions, the previous four cohorts participated in a part-time version of this program over video conferencing.

With generous support from the Helen Gurley Brown Foundation, and in partnership with The Blavatnik Family Women’s Health Institute, the Department of Health Education was able to significantly expand this summer programming, offering a full-time opportunity with a stipend for participating youth.

More than 80 guest speakers—primarily women of color—from across the Mount Sinai Health System, and from local and national organizations, spoke on a variety of issues, broadening participants’ understanding of the many different pathways one can follow into health equity and social justice work. The program featured union labor organizers, doulas, scientists, clinicians, sexuality educators, grassroots activists, researchers, and leaders from city agencies, including the Bureau of Health Equity Capacity Building at the New York City Department of Health and Mental Hygiene, and the New York City Public Advocate Office.

“My favorite part was hearing from the different activists and non-profit workers,” said one participant. “Hearing from both younger people and people who were actively involved in their communities and making a difference was inspiring and presented tangible ways for me to get involved in the community.”

Another participant added, “I loved meeting all the guest speakers and organizations. The most meaningful part was the new relationships I made and learning more about how to help my community.”

Participants completed a culminating project reflective of their summer experience. Each participant selected a public health issue affecting their community, which they documented using a unique photography application. They were then led through a series of semi-structured, dialogue-based activities with staff and peers to support their development of a complementary narrative. This narrative included suggested action steps for those inspired to get involved.

Participants presented their projects at a celebratory symposium on the final day of programming, attended by Mount Sinai staff, community partners, and their family and friends. Their work was featured in a gallery at The Mount Sinai Hospital, and guests were invited to explore.

For many of the participants, spending the summer in a safe space with other girls of color was a profound experience.

When asked about the most meaningful part of the program, responses included:

“Having that space to be myself and being able to express what I am thinking at the moment. Being vulnerable and having that respect that most of the time adults don’t give to teenagers. I loved the relationships that were built in such a short amount of time.”

“Feeling comfortable and welcomed into this space and meeting all these wonderful and intelligent people who inspire me to embrace who I am.”

“Getting to know other people of color that are around my age and listening to everyone’s different opinions and perspectives.”

 

For some participants, learning about the relationship between racism and health was new and eye-opening.

“All the things we talked about and learned about in the program were all new information to me so everything surprised me,” said one. “It surprised me that we aren’t taught these things in school but if we want to gain more knowledge on these topics, we have to learn it on our own or from a program like this. I learned a lot about Black maternal health, homelessness, workers’ rights.”

Many of the participants also appreciated learning more about the various career paths that can contribute to health equity.

“At first I thought I knew what career I wanted to be, to become a nurse practitioner. But I met really nice people in the program who talked about their careers and that gave me more options to be open to my opportunities,” said one. “I also thought that many professionals had one path and that they knew they were going to be where they are now but I learned that there is nothing wrong with switching to a different field and it’s all about being happy that you’re doing that job.”

When asked to share their final thoughts on the program, one participant said, “I truly appreciated having the opportunity to be a part of such a wonderful program. I learned so much from the positive and caring program leaders/educators, the speakers, and the other girls in the program.”

Mount Sinai Researchers Publish First Genome-Wide Analysis of Binge Eating Disorder

Binge eating disorder is the most common eating disorder in the United States, thought to affect as many as 3 percent of people during their lifetimes. Yet it remains poorly understood.

Now, researchers from the Icahn School of Medicine at Mount Sinai have made important progress with the first genome-wide analysis of binge eating disorder (BED). The study, published in Nature Genetics in August, identified genes that appear to be associated with BED risk. The study also found evidence that iron metabolism may play a role in the disease.

“By applying machine learning to the study of binge eating disorder, we’ve gained important insights into this poorly understood condition, and a new tool for exploring other underdiagnosed diseases,” says Panos Roussos, MD, PhD, Professor of Psychiatry, and Genetics and Genomic Sciences at Icahn Mount Sinai and Director of the Center for Disease Neurogenomics, who is a co-author of the study. “By combining Neuroscience with genomics and big data analysis, we can discover more about how the brain works and ultimately prevent psychiatric disease.”

A Fresh Look at Binge Eating Disorder

Binge eating disorder has significant impacts on a person’s health and well-being. “It can cause substantial distress and impairment in quality of life,” says Trevor Griffen, MD, PhD, a psychiatrist and neuroscientist who collaborated on the recent study while he was a fellow in child and adolescent psychiatry at Mount Sinai. “BED often co-occurs with other psychiatric disorders, such as depression, ADHD, and substance use, and seems to be a nexus of metabolic dysfunction, with associations to conditions like diabetes and high blood pressure.”

Trevor Griffen, MD, PhD

Yet it took a long time for the scientific community to recognize BED as a distinct disorder. It was first included as a new diagnosis when the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) was published in 2014. As a result, the diagnosis is all but absent in the electronic health records and large biobanks that researchers tap into for large-scale genetic analyses. Luckily, the Mount Sinai team developed a workaround.

“A big part of this study was using machine learning to figure out the people most likely to have BED,” says lead author David Burstein, PhD, a data scientist at Mount Sinai who works in the labs of Dr. Roussos and study co-author Georgios Voloudakis, MD, PhD, Assistant Professor of Psychiatry, and Genetics and Genomic Sciences.

Using electronic health record data from more than 767,000 people through the Million Veterans Project, Dr. Burstein and his colleagues applied machine learning approaches to sift through medical diagnoses, prescription medicines, body mass index (BMI) data, and other factors, looking for patterns that would predict if a person had BED. Applying their model to smaller cohorts of people with diagnosed BED, they showed the approach could meaningfully predict the disorder, even in the absence of a formal diagnosis.

Genes Point to New Binge Eating Disorder Treatments

Applying the machine learning model to some 362,000 people for whom genetic information was available, the researchers zeroed in on several genetic loci that appear to be associated with BED risk. One of the genes implicated in the new study is MCHR2, which is associated with the regulation of appetite in the brain. Two others, LRP11 and APOE, have previously been shown to play a role in cholesterol metabolism.

David Burstein, PhD

Another gene identified in the study, HFE, is involved in iron metabolism. The identification of HFE aligns with recent research suggesting iron metabolism may have an important role in regulating overall metabolism, Dr. Griffen says. In particular, iron overload seems to be associated with binge eating, the team found. Interestingly, iron deficiency has been implicated in pica, a disorder that drives people to eat non-food items such as soil or hair.

“There have been hints that iron is a player in the eating disorder world,” Dr. Burstein says. “This new study is more evidence that the mineral deserves a closer look.”

The findings also point toward new directions for treating BED. So far, treatment has mostly focused on repurposing therapies used for other disorders, such as depression or ADHD.

“This study identifies genes and systems that could serve as potential targets for treatments that finally address the underlying biology of BED,” Dr. Griffen says. “It also continues to build evidence that there are biological and genetic drivers of binge eating behaviors. The more we get that message out there, the more we can decrease stigma associated with binge eating.”

A New Tool for Eating Disorder Research

Dr. Griffen is continuing to collaborate with Dr. Roussos and Dr. Voloudakis to expand on their findings, with plans to develop mouse models and dig deeper into the mechanisms. Ultimately, their goal is to develop new treatments that target the underlying biology of BED.

Meanwhile, the researchers are eager to apply their new computational approach to other diseases such as bulimia nervosa—another common eating disorder for which no genome-wide analysis has ever been done.

“Being able to infer a diagnosis from medical records is really significant, not only for BED but for other eating disorders, which are often extremely underdiagnosed” and therefore challenging to study using electronic health records, Dr. Burstein says.

The approach can also extend the science into populations that have been overlooked in past research. Most research on eating disorders has focused on white females. Using machine learning, researchers can more thoroughly study eating disorders in males and populations with other racial or ethnic backgrounds.

“This is exciting work, with so many potential future directions,” Dr. Burstein says.

Pin It on Pinterest